A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis

► Let-7/Fas form a double-negative feedback loop which regulates Fas-mediated apoptosis. ► Fas activation suppresses Dicer processing and let-7 microRNA biogenesis. ► Let-7 inhibitor sensitizes colon carcinoma cells to Fas-related apoptosis. Interferon-γ (IFN-γ) is considered essential for the regul...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 408; no. 3; pp. 494 - 499
Main Authors Geng, Li, Zhu, Bin, Dai, Bing-Hua, Sui, Cheng-Jun, Xu, Feng, Kan, Tong, Shen, Wei-Feng, Yang, Jia-Mei
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 13.05.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► Let-7/Fas form a double-negative feedback loop which regulates Fas-mediated apoptosis. ► Fas activation suppresses Dicer processing and let-7 microRNA biogenesis. ► Let-7 inhibitor sensitizes colon carcinoma cells to Fas-related apoptosis. Interferon-γ (IFN-γ) is considered essential for the regulation of anti-tumor reactions as it sensitizes Fas-related apoptosis in HT29 cells, but the mechanism is unclear. In the current study, our data demonstrated that IFN-γ stimulation and Fas activation suppressed Dicer processing and let-7 microRNA biogenesis, while let-7 microRNA strongly inhibited Fas expression by directly targeting Fas mRNA. Accordingly, our results indicate that Fas and let-7 microRNAs form a double-negative feedback loop in IFN-γ and Fas induced apoptosis in colon carcinoma cell line HT29, which may be an important synergistic mechanism in anti-tumor immune response. We also found that a let-7 microRNA inhibitor increased Fas expression and sensitized cells to Fas-related apoptosis, which may have future implications in colon carcinoma therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2011.04.074